Back to Search
Start Over
BCL2L2 loss renders -14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
- Source :
- Clinical and Translational Medicine, Vol 11, Iss 3, Pp n/a-n/a (2021), Clinical and Translational Medicine
- Publication Year :
- 2021
- Subjects :
- lcsh:R5-920
business.industry
bcl-X Protein
Medicine (miscellaneous)
Cancer
medicine.disease
Letter to Editor
Kidney Neoplasms
BCL2L2
Text mining
Cancer research
Molecular Medicine
Medicine
Humans
business
lcsh:Medicine (General)
Apoptosis Regulatory Proteins
Tyrosine kinase
Carcinoma, Renal Cell
Protein Kinase Inhibitors
Subjects
Details
- ISSN :
- 20011326
- Volume :
- 11
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Clinical and translational medicine
- Accession number :
- edsair.doi.dedup.....d83b7434551314741566d06dfd30b90c